InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 11/17/2018

Re: antihama post# 2799

Thursday, 01/30/2020 7:00:28 PM

Thursday, January 30, 2020 7:00:28 PM

Post# of 3283
Wow. Maybe Amgen can just pick up rolontis and market as a biobetter
at a competitive price ( closer to $4000) and gain back market from the
biosimilars. Would be difficult for them to price down further. Someone,
save SPPI